{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidsv6qy2ormwrw64yhlnltkwmnghivxbv2tdrgsrxreogzpr5fzda",
    "uri": "at://did:plc:zqw6y4rgsc4mejxbkvhy4cf4/app.bsky.feed.post/3mmag64d75ev2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifdzrqm6ou7gh77ab7empbgdqhlyy4d6qh5ofqerwgaaqjdamepa4"
    },
    "mimeType": "image/jpeg",
    "size": 212438
  },
  "path": "/star-news/star-national/major-breakthrough-bid-resurrect-giant-moa-rnz",
  "publishedAt": "2026-05-19T21:13:08.000Z",
  "site": "https://www.odt.co.nz",
  "textContent": "Colossal Biosciences Australia-based chief biology officer, Andrew Pask. Photo: Supplied / Colossal Biosciences  \n\n  \n\nBy Mary Argue of RNZ",
  "title": "'Major breakthrough' in bid to resurrect giant moa"
}